Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Integrin M Inhibitors

The chemical class referred to as Integrin M Inhibitors encompasses a diverse range of compounds designed to modulate the activity of Integrin M, a protein crucial for various cellular processes, especially in the context of cell adhesion, migration, and intracellular signaling. The inhibitors in this class target the pathways and processes that are either directly or indirectly associated with Integrin M function. These compounds can interfere with the interaction between Integrin M and its ligands or affect the intracellular signaling pathways that are activated following Integrin M engagement. One method by which these inhibitors can operate is through the modulation of protease activity. Proteases are enzymes that play a vital role in the shedding of cell surface molecules, which in turn can affect the function of Integrin M. By inhibiting these proteases, Integrin M inhibitors can alter the dynamics of cell adhesion and migration, crucial for various cellular functions. Another approach involves the inhibition of specific kinase pathways. Kinases such as MEK, PI3K, p38 MAPK, and Src family kinases are integral to the signaling cascades triggered by Integrin M activation. Inhibitors targeting these kinases can disrupt the downstream signaling events, leading to an alteration in cell migration, survival, and immune responses. These compounds can also affect the cell motility and cytoskeletal dynamics by targeting molecules like ROCK, which are important in the context of Integrin M-mediated cell adhesion and migration.

Additionally, Integrin M inhibitors can influence other signaling molecules like JNK and NF-κB. These molecules are part of broader signaling networks within the cell and can impact the functions related to Integrin M. JNK, for instance, is involved in a variety of cellular responses, including those related to stress, inflammation, and apoptosis. By inhibiting JNK, these compounds can modulate the cellular responses linked to Integrin M activation. NF-κB, a crucial molecule in numerous cell signaling pathways, including those linked to integrins, can also be targeted by these inhibitors. By modulating NF-κB activity, these compounds can influence the cellular processes associated with Integrin M. Overall, Integrin M Inhibitors represent a class of compounds with a broad spectrum of activity, affecting various aspects of cell biology through multiple mechanisms. Their ability to target different molecules and pathways associated with Integrin M allows for a multifaceted approach to modulating the function of this integrin, making them a significant focus in the study of cellular processes related to cell adhesion, migration, and signaling. Their diverse mechanisms of action reflect the complex nature of integrin-mediated cellular functions and the intricate networks of signaling pathways involved.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

TAPI-2

187034-31-7sc-205851
sc-205851A
1 mg
5 mg
$286.00
$1019.00
15
(1)

TAPI-0 is a metalloprotease inhibitor. It could possibly inhibit Integrin M by affecting the shedding of cell surface molecules that interact with Integrin M, altering cell adhesion and migration.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an MEK inhibitor. It could possibly inhibit ITGAL by influencing the MAPK/ERK pathway, which is involved in integrin-mediated signaling, potentially affecting Integrin M-related cellular processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. By inhibiting PI3K, it could possibly inhibit Integrin M by affecting the PI3K/AKT pathway, which is linked to integrin signaling. This could alter Integrin M-mediated cell adhesion and migration.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. It could possibly inhibit Integrin M by influencing the p38 MAPK pathway, which is involved in integrin signal transduction, affecting cell adhesion and migration.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

PP2 is an Src family kinase inhibitor. It could possibly inhibit Integrin M by affecting Src kinases, which are involved in integrin signaling, impacting cell migration and immune response.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a ROCK inhibitor. It could possibly inhibit Integrin M by affecting ROCK, which is involved in cell motility and cytoskeletal dynamics, important in Integrin M-mediated cell adhesion and migration.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor. By inhibiting PI3K, it could possibly inhibit Integrin M by affecting Integrin M-mediated signaling pathways, particularly affecting cell migration and survival.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is a broad spectrum tyrosine kinase inhibitor. It could possibly inhibit Integrin M by inhibiting kinases involved in integrin signaling, impacting cell adhesion and migration.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor. By inhibiting JNK, it could possibly inhibit Integrin M by affecting related signaling pathways, potentially altering cellular responses like adhesion and migration.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

BAY 11-7082 inhibits NF-κB activation. NF-κB is involved in various cell signaling pathways including those linked to integrins, and could possibly inhibit Integrin M by influencing these functions.